Abstract
In some studies in diabetic people, chromium picolinate supplementation has lowered readings for both plasma triglycerides and blood sugar. In the present study, relatively low dose supplementation (200 µg chromium) did not lower blood sugar readings, but did lower triglyceride values in people with the following characteristics: type 2 diabetes, moderately elevated blood sugar, and not using insulin therapy. These results support the supposition that chromium picolinate can affect triglyceride concentrations independently of effects on carbohydrate metabolism. Key words: Chromium, diabetes, triglycerides.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
